(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(1.45%) $922.85
(0.04%) $0.927
(0.13%) $10.85
(0.00%) $0.792
(0.12%) $92.55
Live Chart Being Loaded With Signals
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy...
Stats | |
---|---|
Today's Volume | 1.27M |
Average Volume | 666 390 |
Market Cap | 142.76M |
EPS | $-0.0700 ( 2024-02-09 ) |
Next earnings date | ( $-0.0600 ) 2024-05-10 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.45 |
ATR14 | $0.00300 (0.34%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-14 | Smith Robert Joseph | Buy | 75 000 | Stock Option (Right to Purchase Common Stock) |
2024-03-12 | Smith Robert Joseph | Buy | 0 | |
2023-10-10 | Webb Carol | Buy | 75 000 | Options to Purchase Common Stock |
2023-10-10 | Czuczman Myron | Buy | 300 000 | Stock Option (Right to Purchase Common Stock) |
2023-10-10 | Holubiak Myron Z | Buy | 400 000 | Options to Purchase Common Stock |
INSIDER POWER |
---|
100.00 |
Last 96 transactions |
Buy: 26 139 757 | Sell: 73 267 |
Volume Correlation
Citius Pharmaceuticals Correlation
10 Most Positive Correlations | |
---|---|
FICS | 0.886 |
HEAR | 0.877 |
RNEM | 0.868 |
VIGI | 0.866 |
NTRSO | 0.865 |
RMRM | 0.861 |
PID | 0.86 |
TCON | 0.856 |
TZOO | 0.856 |
GAINL | 0.854 |
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Citius Pharmaceuticals Correlation - Currency/Commodity
Citius Pharmaceuticals Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-194 316 (0.00 %) |
EPS: | $-0.220 |
Q4 | 2023 |
Revenue: | $0 |
Gross Profit: | $-49 969.00 (0.00 %) |
EPS: | $-0.0626 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $-49 017.00 (0.00 %) |
EPS: | $-0.0551 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $-48 143.00 (0.00 %) |
EPS: | $-0.0720 |
Financial Reports:
No articles found.
Citius Pharmaceuticals
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections by salvaging the infected catheter; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a corticosteroid-lidocaine topical formulation that intends to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome; and I/ONTAK, an engineered IL-2 diphtheria toxin fusion protein for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators